PROSTIN VR PEDIATRIC

LOE Approaching

alprostadil

Pfizer
NDAINJECTIONINJECTABLEPriority Review
Approved
Oct 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2

Mechanism of Action

Prostaglandin Receptor Agonists

Pharmacologic Class:

Prostaglandin Analog

Clinical Trials (2)

NCT00619229Phase 3Terminated

Alprostadil in Maculopathy Study (AIMS)

Started Jul 2006
37 enrolled
Macular Degeneration
NCT00596752Phase 4Completed

Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV

Started Mar 2004
840 enrolled
Peripheral Arterial Occlusive Disease
Company
Pfizer
Pfizer
NEW YORK, NY
589 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers